VITRANU
Vitranu provides a platform technology to fulfill the unmet need for sustained, controllable ophthalmic drug delivery. They develop a tunable extended-release capsule for biologic pharmaceuticals.
VITRANU
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2020-01-01
Address:
Columbus, Ohio, United States
Country:
United States
Website Url:
http://www.vitranu.com
Total Employee:
1+
Status:
Active
Total Funding:
1.51 M USD
Technology used in webpage:
Squarespace Hosted
Similar Organizations
Enterin
Philadelphia-based biotechnology company .
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Synhitech
Synhitech develops sustainable alternative processes to produce biochemicals and pharmaceuticals.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.vitranu.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Vitranu"
Vitranu
Vitranu’s patent pending TERCâ„¢ technology aims to meet this need by reducing eye injections to 2 per year or fewer. TERCâ„¢ is the Tunable Extended-Release Capsule technology that enables the sustained delivery of therapeutics in vivo.See details»
Vitranu - Crunchbase Company Profile & Funding
Vitranu develops novel extended administration drug delivery technology. View contacts for Vitranu to access new leads and connect with decision-makers. Vitranu provides a platform …See details»
Team - Vitranu
John Black has nearly 20 years of experience in the medical industry, holding senior leadership roles across both startups and well-established organizations. With a background in both allied …See details»
Vitranu Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Vitranu. Use the PitchBook Platform to explore the full profile.See details»
Vitranu - VentureRadar
Vitranu is developing a Tunable Extended Release Capsule (TERC) for biologic pharmaceuticals and small molecules delivered via intravitreal injection, with a lead indication of wet Age …See details»
Vitranu - LinkedIn
A Vision for Fewer Eye Injections. | Vitranu is developing a Tunable Extended Release Capsule (TERCâ„¢) for sustained delivery of therapeutics to the eye via intravitreal injection.See details»
Vitranu - Overview, News & Similar companies | ZoomInfo.com
View Vitranu (www.vitranu.com) location in Ohio, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Vitranu - Funding, Financials, Valuation & Investors - Crunchbase
Vitranu develops novel extended administration drug delivery technology.See details»
Vitranu - Contacts, Employees, Board Members, Advisors & Alumni
Vitranu develops novel extended administration drug delivery technology.See details»
Vitranu - Products, Competitors, Financials, Employees, …
Vitranu focuses on developing medical technology for sustained therapeutic delivery, specifically within the ophthalmology sector. The company's main innovation is the TERCâ„¢, a Tunable …See details»
Vitranu - Products, Competitors, Financials, Employees, …
Vitranu is developing a Tunable Extended-Release Capsule (TERC) for biologic pharmaceuticals delivered via intravitreal injection. Use the CB Insights Platform to explore Vitranu's full profile.See details»
Vitranu | Rev1 Ventures
Https://www.vitranu.com Company Profile Vitranu’s patent pending TERCâ„¢ technology, the innovative Tunable Extended-Release Capsule for sustained delivery of therapeutics, aims to …See details»
Vitranu - Crunchbase
Vitranu develops novel extended administration drug delivery technology.See details»
Professor recognized for innovative research on treatments for …
She said this technology is the basis for Vitranu Inc. — a Columbus-based startup aimed at bringing the capsule to market for clinical use and where Swindle-Reilly is the chief technology …See details»
Vitranu | ICFO WEBSITE - iCFO Capital
Vitranu is developing the Tunable Extended-Release Capsule or TERC, a sustained-release drug delivery technology designed to significantly reduce the frequency of eye injections, with the …See details»
Matthew Ohr - Vitranu - LinkedIn
Interim Chair and Retina Division Director at The Ohio State University Department of… · Experience: Vitranu · Education: Wright State University …See details»
Gordon Bethwaite - Crunchbase Person Profile
Gordon Bethwaite currently works as the Founder & Chief Executive Officer for Vitranu, Inc. & he Attended Liverpool John Moores University in 1993.See details»
vitrana Reviews: What Is It Like to Work At vitrana? | Glassdoor
Sep 10, 2024 · vitrana has an employee rating of 3.6 out of 5 stars, based on 75 company reviews on Glassdoor which indicates that most employees have a good working experience …See details»
Debt Financing - Vitranu - 2021-10-25 - Crunchbase
Oct 25, 2021 · Vitranu raised $1511000 on 2021-10-25 in Debt FinancingSee details»
Vitranu - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Vitranu develops a tunable extended-release capsule for biologic pharmaceuticals.See details»